These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Neoadjuvant chemotherapy for osteosarcoma]. Guo W; Yang RL; Tang XD; Tang S; Li DS; Yang Y Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1186-90. PubMed ID: 15387981 [TBL] [Abstract][Full Text] [Related]
6. Combination chemotherapy for osteosarcoma. Pratt CB; Rivera G; Shanks E; Kumar AP; Green AA; George S Cancer Treat Rep; 1978 Feb; 62(2):251-7. PubMed ID: 346214 [TBL] [Abstract][Full Text] [Related]
8. A comparative clinical trial evaluating the combination of adriamycin, DTIC, and vincristine, the combination of actinomycin D, cyclophosphamide, and vincristine, and a single agent, methyl-CCNU, in advanced sarcomas. Creagan ET; Hahn RG; Ahmann DL; Edmonson JH; Bisel HF; Eagan RT Cancer Treat Rep; 1976 Sep; 60(9):1385-7. PubMed ID: 189922 [No Abstract] [Full Text] [Related]
9. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Bramwell V; Rouesse J; Steward W; Santoro A; Schraffordt-Koops H; Buesa J; Ruka W; Priario J; Wagener T; Burgers M J Clin Oncol; 1994 Jun; 12(6):1137-49. PubMed ID: 8201375 [TBL] [Abstract][Full Text] [Related]
10. Pirarubicin versus doxorubicin in neoadjuvant/adjuvant chemotherapy for stage IIB limb high-grade osteosarcoma: does the analog matter? Yu W; Tang L; Lin F; Yao Y; Shen Z Med Oncol; 2015 Jan; 32(1):307. PubMed ID: 25432694 [TBL] [Abstract][Full Text] [Related]
11. [Neoadjuvant therapy for localized osteosarcoma of extremities. Results from the Cooperative osteosarcoma study group COSS of 925 patients]. Bielack S; Kempf-Bielack B; Schwenzer D; Birkfellner T; Delling G; Ewerbeck V; Exner GU; Fuchs N; Göbel U; Graf N; Heise U; Helmke K; von Hochstetter AR; Jürgens H; Maas R; Münchow N; Salzer-Kuntschik M; Treuner J; Veltmann U; Werner M; Winkelmann W; Zoubek A; Kotz R Klin Padiatr; 1999; 211(4):260-70. PubMed ID: 10472560 [TBL] [Abstract][Full Text] [Related]
12. [Preoperative adjuvant therapy for primary malignant bone tumors]. Goto T; Okuma T; Nakada I; Hozumi T; Kondo T Gan To Kagaku Ryoho; 2007 Nov; 34(11):1750-4. PubMed ID: 18030009 [TBL] [Abstract][Full Text] [Related]
13. Chemotherapy, en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma. Rosen G; Murphy ML; Huvos AG; Gutierrez M; Marcove RC Cancer; 1976 Jan; 37(1):1-11. PubMed ID: 1082364 [TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy of metastatic malignant schwannoma with vincristine, adriamycin, cyclophosphamide, and imidazole carboxamide: a case report. Goldman RL; Jones SE; Heusinkveld RS Cancer; 1977 May; 39(5):1955-8. PubMed ID: 858125 [TBL] [Abstract][Full Text] [Related]
15. Osteosarcoma: review of the past, impact on the future. The American experience. Jaffe N Cancer Treat Res; 2009; 152():239-62. PubMed ID: 20213394 [TBL] [Abstract][Full Text] [Related]
16. [Preoperative and postoperative chemotherapy of osteogenic sarcoma of the limbs in children]. Muñoz Villa A; Ocete G; Aymerich ML; Maldonado S; Otheo E; Calvo M; Amaya J Med Clin (Barc); 1996 Jun; 107(5):161-4. PubMed ID: 8758673 [TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemotherapy for the treatment of osteosarcoma of the extremities: excellent response of the primary tumor to preoperative treatment with methotrexate, cisplatin, adriamycin, and ifosfamide. Preliminary results. Bacci G; Picci P; Ferrari S; Sangiorgi L; Mercuri M; Bertoni F; Brach del Prever A; Tienghi A; Mancini A; Comandone A Chir Organi Mov; 1995; 80(1):1-10. PubMed ID: 7641534 [TBL] [Abstract][Full Text] [Related]
18. [Responses of 109 adult soft tissue sarcoma patients to chemotherapy]. Qiu MZ; Xu F; Wang SS; Luo HY; Wang F; Li FH; Sun XF; Xu GC; Lin TY; Huang HQ; Jiang WQ; Guan ZZ; Xu RH Ai Zheng; 2007 Dec; 26(12):1344-9. PubMed ID: 18076798 [TBL] [Abstract][Full Text] [Related]
19. Adjuvant therapy for nonmetastatic osteogenic sarcoma: an evaluation of transfer factor versus combination chemotherapy. Gilchrist GS; Ivins JC; Ritts RE; Pritchard DJ; Taylor WF; Edmonson JM Cancer Treat Rep; 1978 Feb; 62(2):289-94. PubMed ID: 346219 [TBL] [Abstract][Full Text] [Related]